Henk van Loveren Maastrick University, National Institute of Public Health and the Environment, The Netherlands 1 Overview and

Size: px
Start display at page:

Download "Henk van Loveren Maastrick University, National Institute of Public Health and the Environment, The Netherlands 1 Overview and"

Transcription

1 日本免疫毒性学会 :The Japanese Society of Immunotoxicology Vol. 17 No. 2( 通巻 34 号 )2012 aa aa 東京慈恵会医科大学 東海大学医学部 ( 独 ) 科学技術振興機構 独立行政法人国立環境研究所環境健康研究センター 川崎医科大学衛生学 Meiji Seika ファルマ株式会社 大阪大学大学院薬学研究科毒性学分野博士後期課程 1 年 筑波大学大学院生命環境科学研究科持続環境学専攻 2 年次 連携大学院国立環境研究所環境健康研究センター 分子毒性機構研究室 アサマ化成株式会社 大阪大学免疫学フロンティア研究センターワクチン学研究室 独立行政法人国立環境研究所 Tin Tin Win Shwe 第一三共株式会社安全性研究所 大阪大学大学院薬学研究科毒性学分野 English pages 柳澤裕之 ( 東京慈恵会医科大学環境保健医学講座 ) JSIT takanawa/index.html JR Notch/NotchL 28 PC F A X sakabek@tokai-u.jp 1

2 Henk van Loveren Maastrick University, National Institute of Public Health and the Environment, The Netherlands 1 Overview and Application of the WHO/IPCS Harmonized Guidance for Immunotoxicity Risk Assessment for Chemicals AIM Apoptosis Inhibitor of Macrophage.. In vitro immunotoxicology Emanuela Corsini Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Faculty of Pharmacy, Universita degli Studi di Milan, ItalyCurrent Trend on In Vitro Immunotoxicology in EU in vitro h-clat Ai-Young Lee Department of Dermatology, Dongguk University Ilsan Hospital, South Korea Irradiation of light emitting diode at 850 nm inhibits T cell-induced cytokine expression Evaluation of anti-drug antibodies during non-clinical safety studies Gray Bembridge (Huntingdon Life Sciences Ltd.) 2

3 Vol. 17 No. 2 (2012) 2 Lawrence D Jacob Charles River Laboratories services 2 Validation and use of several assays to monitor pharmacodynamic markers intended for human use, in the cynomolgus monkey Meiji Seika Human cell line activation Test h-clat senescence p130 6 藤巻秀和学術 編集委員会 : Dr. Jack H. Dean University of Arizona Professor Jacques Descotes Lyon Poison Center 奨励賞 小池英子 ( 独立行政法人国立環境研究所環境健康研究センター ) 24 O 3 NO 2 PM2.5/DEP PM DEP 3

4 DINP NC/Nga DINP TSLPTSLP Th2 DINP BMDC in vitrodinp BMDC Th2 TARC MDC CCR7 CXCR4 MHC class II CD86 T IL-4 DINP IL-4 DINP TTh2 西村泰光 ( 川崎医科大学衛生学 ) Senescence Accelerated Mice, SAM 1970 SAM SAM ? AM TGF- Bcl-2/Bcl-x L AM

5 Vol. 17 No. 2 (2012) NK NK NKp46 NK PBMC NK 年会賞 Human cell line activation Test h-clat 打田光宏 1 土屋敏行 1 宇梶真帆 2 斎藤嘉朗 2 黒瀬光一 2 ( 1 : Meiji Seika ファルマ株式会社 2 : 国立衛研 医薬安全科学部 ) active systemic anaphylaxis passive cutaneous anaphylaxis in vitro THP-1 human Cell Line Activation Test h-clat h-clat 18 1 h-clat 18 CV75 75% 11 ampicillin sodium D-penicillamine ticlopidine hydrochloride cephalothin sodium diclofenac sodium levofloxacin hydrochloride gefitinib albendazole amiodarone hydrochloride carbamazepine pravastatin sodium 7 phenitoin hydrocortisone penicillin G potassium nevirapine acetyl salicylic acid allopurinol amoxicillin CV75 hclat 19 Negative compound? DMSO 5

6 ??? CV75? 1, Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-clat). I. Optimization of the h-clat protocol. Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H, Miyazawa M, Ito Y, Suzuki H, Toyoda H. Toxicol In Vitro Aug;20( 5 ): 学生若手優秀賞 平井敏郎 ( 大阪大学大学院薬学研究科毒性学分野博士後期課程 1 年 ) nm Hirai T et al. Part. Fibre Toxicol IgG/IgE 6

7 Vol. 17 No. 2 (2012) senescence p 岡村和幸 ( 筑波大学大学院生命環境科学研究科持続環境学専攻 2 年次 連携大学院国立環境研究所環境健康研究センター 分子毒性機構研究室 ) senescence p BA20 A20 10 M 8 14 senescence senescence senescence senescence H 2 O 2 A20 H 2 O M 5 H 2 O 2 senescence G0/G1 arrest H 2 O 2 G2/M arrest H 2 O 2 24 G0/G1 arrest p130 p130 H 2 O 2 p130 p130 G0/G1 arrest sirna p130 G0/G1 arrest A20 senescence G0/G1 arrest p 投 稿 塩野谷博 ( アサマ化成株式会社研究顧問 ) ,3,

8 in vitro 3,5-2 3, I - I - 1 /2I 2 I 2 > > X XX 6 6 5,6 in vitro ,5- Nilsson R X in vivo. 3 2 ~-4 IgE 3,5 RASTIgE IgG ECL IgG T4 2 T4 IgERAST

9 Vol. 17 No. 2 (2012) PCA I - I - I ,11 Mikkonen R % ~ 7 46% r=0.613 p< Munechika H / % 7 ~ 9 193/ % 2 p<0.01 Oxygen burst 12,13. IgE IgE IgE , Shionoya H et al. Studies on experimental iodine allergy: 1. Antigen recognition of guinea pig antiiodine antibody. J Toxicol Sci 29: , Shionoya H, et al.: Studies on experimental iodine 9

10 allergy: 2. Iodinated protein antigens and their formation from inorganic and organic iodinecontaining chemicals. J Toxicol Sci 29, , Sugihara Y, et al.: Studies on experimental iodine allergy: 3. Low molecular weight elicitogenic antigens of iodine allergy. J Toxicol Sci 29: , Wolf GL et al,: A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: Comparison of adverse effects. Am J Roentgenol 152, , Katayama H, et al.: Adverse reactions to ionic and nonionic contrast media. A report from Japanese Committee on the Safety of Contrast Media. Radiology, 175: , Nilsson R et al.: Formation of potential antigens from radiographic contrast media. Acta Radiologica 28: , Girard JP, Gamba L,: Radiologic contrast media. In allergic reactions to drugs de Weck AL and Bundgaard H. eds. Handb Exp Pharm, 63: , Mikkonen R, et al.: Seasonal variation in the occurrence of late adverse skin reaction to iodinebased contrast media. Acta Radiol, 41: , Munechika H, et al.: A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol, 13: , Emelyanov A, et al.: Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest, 120: , Vargas L.: A study of granulocyte respiratory burst in patients with allergic bronchial asthma. Inflammation, 22:45-54, Sato K et al.: Occupational allergy in medical doctors. J Occup Health 46: 新評議員より Dirty Little Secret 黒田悦史 ( 大阪大学免疫学フロンティア研究センターワクチン学研究室 ) 2008 Nature Science 80 Immunologist, s Dirty Little Secret

11 Vol. 17 No. 2 (2012) Dirty Little Secret Tin Tin Win Shwe ( 独立行政法人国立環境研究所 ) 河井良太 ( 第一三共株式会社安全性研究所 ) RT-PCR VOC in vivo, in vitro SOA SOA IH Brown Norway Rat 20 DEP 9 T TDAR TDAR 11

12 吉岡靖雄 ( 大阪大学大学院薬学研究科毒性学分野 ) nm 10 nm Nano-Safety Science Nano-Safety Design Sustainable Nanotechnology 世界の免疫毒性研究者へのインタビュー第 3 回 Real Voices of International Immunotoxicologists 3 Real Voices of International Immunotoxicologists 19 Henk Van Loveren Emanuela Corsini Ai-Young Lee EUROTOX JSIT English 12

13 Vol. 17 No. 2 (2012) ImmunoTox Letter 2 20 WHO S.H 発行日 : 平成 24 年 12 月 keikon@nies.go.jp 13

20●12頁●6-14▲放射線科▲.ppt

20●12頁●6-14▲放射線科▲.ppt No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

More information

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

More information

CHEMOTHERAPY Fig. 1 Chemical structure of TE-031

CHEMOTHERAPY Fig. 1 Chemical structure of TE-031 CHEMOTHERAPY Fig. 1 Chemical structure of TE-031 CHEMOTHERAPY Table 1 Experimental groups for active systemic anaphylaxis in guinea pigs : Single dosage Fig. 2 Schedule for active systemic anaphylaxis

More information

untitled

untitled 1 2 3 http://www.info.pmda.go.jp/ 4 5 6 7 8 9 10 11 (Quincke s edema) 12 13 梗 疼 () 14 15 J Allergy Clin Immunol 115;S483-S523, 2005 16 17 IgE IgE IgE 18 19 20 21 腿 22 Hydrocortisone 100 200 mg 5 mg/kg

More information

ニュースレター10-1.indd

ニュースレター10-1.indd The Japanese Society of Immunotoxicology 101192005 aaaa 12 2005172021 1-1-1 Tel. 03-5841-8205 / Dr. R.H. Pieters () "Immunotoxicology of therapeutics associated with allergy and autoimmunity" 2005 In

More information

VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity

VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity CHEMOTHERAPY MAR. 1989 Mble 1. Allcrgy in parients nduced by penams VOL. 37 NO. 3 Table 2. Allergy in patients induced by

More information

Special IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them

More information

History I COE

History I COE 2008 108-8641 5-9-1 TEL 03-5791-6334FAX 03-5791-6335 e-mailgakufu@lisci.kitasato-u.ac.jp 228-8555 1-15-1 TEL 042-778-9760FAX 042-778-9761 e-mailnyushi@kitasato-u.ac.jp URL http://www.kitasato-u.ac.jp/lisci/index.html

More information

2009年度 東京薬科大学 薬学部 授業計画

2009年度 東京薬科大学 薬学部 授業計画 2009 2 234 Tokyo University of Pharmacy and Life Sciences since 880 Tokyo University of Pharmacy and Life Sciences Department of Clinical Pharmacy Men's Division Department of Clinical Applied Pharmacy

More information

MV X 5 6 Common Terminology Criteria for Adverse Events Grade 1 Grade Gy 16 QOL QOL 5 6 7, 8 9, VOL.3 NO

MV X 5 6 Common Terminology Criteria for Adverse Events Grade 1 Grade Gy 16 QOL QOL 5 6 7, 8 9, VOL.3 NO 乳がん患者の放射線皮膚炎に対するスキンケアの指導の実際 がん放射線療法看護認定看護師とがん放射線治療に携わる看護師との比較 Educating practice of skin care for radiodermatitis of breast cancer patients: Comparison of the nurses with certified nurse in radiation therapy

More information

研究成果報告書(基金分)

研究成果報告書(基金分) (1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant

More information

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter 3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh

More information

Unknown

Unknown Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.3 July 2013 Report The 30 th Meeting of Japan Association of Breast and Thyroid Sonology... 1 Department of Organ

More information

æ æ2 \ R esults of Open Patch Tests in Control Solutions Containing Ammonium Thioglycollate or Cysteine Group Using Cold Permanent Wave 3 \ Results of

æ æ2 \ R esults of Open Patch Tests in Control Solutions Containing Ammonium Thioglycollate or Cysteine Group Using Cold Permanent Wave 3 \ Results of æ æ2 \ R esults of Open Patch Tests in Control Solutions Containing Ammonium Thioglycollate or Cysteine Group Using Cold Permanent Wave 3 \ Results of Patch Tests Using Cold Permanent Wave Solutions on

More information

Abbreviation: AD; atopic dermatitis, BA; bronchial asthma, DA; drug allergy, FA; food allergy, BAST; radioallergosolvent test, s. c; subcutaneous

Abbreviation: AD; atopic dermatitis, BA; bronchial asthma, DA; drug allergy, FA; food allergy, BAST; radioallergosolvent test, s. c; subcutaneous Abbreviation: AD; atopic dermatitis, BA; bronchial asthma, DA; drug allergy, FA; food allergy, BAST; radioallergosolvent test, s. c; subcutaneous Fig. I Total serum IgE and IgE RAST score of egg white

More information

2012

2012 2012 2012 http://www.hiroshima-cu.ac.jp 2012 006 048 050 051 053 055 056 114 115 118 119 120 121 124 130 134 135 136 137 140 163 165 167 169 060 061 062 063 064 065 066 067 068 069 070 071 073 078 079

More information

校了ニュースレター16-1.indd

校了ニュースレター16-1.indd 日本免疫毒性学会 :The Japanese Society of Immunotoxicology Vol. 16 No. 1( 通巻 31 号 )2011 aa 目次 aa 免疫毒性学の課題 1 食品薬品安全センター秦野研究所 研究顧問小野宏 第 18 回日本免疫毒性学会学術大会 ( 予告 2) 1 千葉大学上野光一 非臨床アレルゲン性試験の現状と課題 3 独立行政法人医薬品医療機器総合機構澤田純一

More information

リスクコミュニケーション概論

リスクコミュニケーション概論 1 2005 7 2 http://hideyukihirakawa.com/ Contents 1. 2. 3. 4. 2 1. (Alvin Weinberg, 1972) e.g. etc 3 4 2. 5 NRC, 1989; Codex, 2004 ( ) ( ) NGO 6 2 (TRUSTNET: Dubreuil et al, 2002) www.trustnetgovernance.com

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

5 I The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthenin

5 I The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthenin 5 I. 3 1 1990 2 The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthening North Pacific Cooperation organized by the East-West

More information

8 8.1 Lieberman; db Kisilevsky; 1989 Hartikainen; db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; ,000 2,500g 13 Lagers

8 8.1 Lieberman; db Kisilevsky; 1989 Hartikainen; db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; ,000 2,500g 13 Lagers 8 8.1 Lieberman; 1975 100 105 db Kisilevsky; 1989 Hartikainen; 1994 78 db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; 1978 713 40,000 2,500g 13 Lagerstrom et al.; 1991 Rantakallio; 1985, McDermott et al.;

More information

2011 Vol.53 No.2 Jpn J School Health Jpn J School Health Tokushima University Ibaraki University Nihon University Jpn J School Health Jpn J School Health Jpn J School Health Jpn J School Health Graduate

More information

The Bulletin of the Institute of Human Sciences, Toyo University, No. 7 The Semantic Role and Function of GA and WO as object markers in Japanese WANG Yaxin The purpose of this paper is to analyze the

More information

第80回日本温泉気候物理医学会.indd

第80回日本温泉気候物理医学会.indd 第80回 The 80 th Annual Meeting of the Japanese Society of Balneology, Climatology and Physical Medicine 日本温泉気候物理医学会 総会 学術集会 プログラム 抄録集 温泉の恵み 自然の力 会 期 会 場 会 長 2015 年 6月20日 21日 軽井沢プリンスホテル ウェスト 倉 林 均 埼玉医科大学リハビリテーション医学教授

More information

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( ) 212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................

More information

糖尿病薬の保険調剤 留意事項など

糖尿病薬の保険調剤留意事項など E-mail; west@gifu-shiya k u.ne t supported by 2 Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study S. Skurtveit*, H. Strøm*,

More information

356 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -/0-0+ (,**1) 44 For Quality Control and Quality Assurance in Food Analysis Akemi Yasui Analyt

356 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -/0-0+ (,**1) 44 For Quality Control and Quality Assurance in Food Analysis Akemi Yasui Analyt 356 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -/0-0 (,**1) 44 For Quality Control and Quality Assurance in Food Analysis Akemi Yasui Analytical Science Division, National Food Research Institute,

More information

CAS H 3 C C CH 2 C 9 H tert d = hpa

CAS H 3 C C CH 2 C 9 H tert d = hpa 1 200140 35 CAS 98839 1335-2- H 3 C C CH 2 C 9 H 10 118.18 1 99 4-tert- 1. 2-23.2 2 163164 2 54 574 3 0.96.6 20 d 4 0.9082 2 4.07 = 1 2.5 hpa 1.9 mmhg20 2 4 log Pow3.48 3.44 m/z 118, 1.0 103 0.58 91 0.21

More information

040202PC用.doc

040202PC用.doc 15 48 15 8 25 15 1321 15 8 25 0825002 15 8 25 6 8 15 2 18 15 6 27 2 15 3 13 28 35 (1) 51 198 7 (2) 3 6 1 100g (1) 1 (1) 1 2 1 astaxanthin;3,3 -dihydroxy-, -carotene-4,4 -dione (2) 1 2 C40H52O4 596.86 97.0

More information

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版 ...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

More information

untitled

untitled 1 2 21-3 CS VOC- CS syasuma@tc4.so-net.ne.jp 4 [] MCS, 200501212B () SHSMCS CS 66 14 16 5 () MCS 16 (GSTs) 14 (8ppb40ppb) 2002192155-161) 6769 68 68 EPA Terr, 1989 69 QEESI 3 70 6 EPA MCS 10 9 8 MCS 6

More information

4703ALL01

4703ALL01 473201010 *** (1999) 16 2017 20023 2 1 2 1220 (1999a),(1999b) (1998), (2002) (2003)(1999)(2003) Conjoint Analysis Conjoint Analysis Willingness to PayStandard gamble Time trade-off Rating Scale Willingness

More information

Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone

Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone (inoculum size= 106 CFU/ml) (Ĉ-lactamase producer : 2 strains) Fig. 1. Sensitivity distribution of

More information

/‚“1/ŒxŒ{‚×›î’æ’¶

/‚“1/ŒxŒ{‚×›î’æ’¶ 60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:

More information

兵庫県立大学学報vol.17

兵庫県立大学学報vol.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 THE UNIVERSITY OF HYOGO NEWS 2014 VOL.17 School of Human Science and Environment

More information

2 R K/S K/S K/S K/S K/S K/S K/SR R K/S K/S K/S K S R K/S K/S K/S K/S K/S K/S

2 R K/S K/S K/S K/S K/S K/S K/SR R K/S K/S K/S K S R K/S K/S K/S K/S K/S K/S Graduate School of Environment and Information Sciences, Yokohama National University, Yokohama 240 8501 Faculty of Education and Human Sciences, Yokohama National University, Yokohama 240 8501 Keywords:

More information

untitled

untitled The 42 nd Annual Meeting of Japan Brain Science society 42 2015 111213 42 1. 2. 3. 4. 5. 1. 2. 3. 4. 10 http://www.anahirmiyazaki.com/ 10 269 220 ANA 2 2 1000 1016 930 946 1110 1126 1040 1056 1340 1356

More information

Special IssueOncology Nutrition Reviews Proceeding DNA β Nutrition and physical activity and the prevention of cancer Yutaka Taketani Department of Clinical Nutrition, Institute of Health Biosciences,

More information

第14〜15回 T細胞を介する免疫系.pptx

第14〜15回 T細胞を介する免疫系.pptx MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α

More information

研究開発評価活動の実例集 3. 6)琉球大学における評価活動について

研究開発評価活動の実例集 3. 6)琉球大学における評価活動について 1 / 12 ページ 2 / 12 ページ 3 / 12 ページ 4 / 12 ページ 5 / 12 ページ 6 / 12 ページ 7 / 12 ページ 8 / 12 ページ 9 / 12 ページ 資料 1 A dministrative Structure Chart M anagement C ouncil I nspector Pr esident B oar d of C ouncil C

More information

untitled

untitled Vol.2 o.10 (2004/05/27) MRA.1 [ Desyrel ] trazodone hydrochloride FDA.2 [ Zelnorm ] tegaserod hydrogen maleate ealth Canada.3 ealth Canada.5 [ Viread ] tenofovir disoproxil fumarate ealth Canada.5 [ rthoclone

More information

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS < > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic

More information

技術の系統化調査報告「医療用X線CT技術の系統化調査報告」

技術の系統化調査報告「医療用X線CT技術の系統化調査報告」 Historical Development of X-Ray Computed Tomography for Medical Use 2 Yoshiki Hirao Abstract Yoshiki Hirao 85 1 2 2.1 2.3 2.2 2.4 86 Vol.12 2008.March 87 2.5 2.6 88 Vol.12 2008.March 89 2.7 2.8 90 Vol.12

More information

untitled

untitled CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11

More information

橡Taro13-FDアンケート (教員)

橡Taro13-FDアンケート (教員) Institute for Higher Education Research 1972 5 2002 30 113 20 5 academic work academic productivity human resources teaching 21 21 2003 1989 2003 2003 Study of the Institutionalization of Faculty Development

More information

MM0506-Ariyoshi.ind

MM0506-Ariyoshi.ind 51 2005133 Six years of experiences at the U.K. MRC Laboratories, The Gambia, in West Africa Koya ARIYOSHI 130 1965 1992 Jonathan Weber Medical Research Council MRC Laboratories, The Gambia HIV Virologist/Immunologist

More information

AAS48.indd

AAS48.indd Suzuki K. (2016). Breeding for disease resistance to Mycoplasma pneumonia of swine All about SWINE 48, 2-12 PRDC ARMPS PRRS 18 1 21 24 32 40 MPS EU 2006 2011 SPF 2 3 MPS 5 MPS 4 MPS MPS MPS 2 MPS MPS MPS

More information

NEWS LETTER No.10 (Page 1)

NEWS LETTER No.10 (Page 1) Who When Where What Why How Who When Where What Why How U.S. Department of Agriculture / U.S. Department of Health and Human Services Guide Line PEOPLE'S REPUBLIC OF CHINA GUIDE LINE NORWAY WHO WHEN WHERE

More information

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS < > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic

More information

&

& & & & c & B & c & & aa c c a a nk a a & a aa aaa & A A A A & 7 & & c og og & c c k g a og ok c c & 7 7 n & aa & & & & & & & & & & & g & & a a & & 171 1 & 1 7 1 1 6 de 666 66 6 7 6 f 6 & & c & 1 1 1 1 1

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

untitled

untitled 38 2013 ITAA in OSAKA 2013 81517 38 2013 ITAA in OSAKA 2013 815 17 38 2013 ITAA in OSAKA P01 1001 1002 1004 1005 1010 10F 12F 830 900 8 15 8 16 8 17 830 900 915 1000 1100 1200 10001145 1 10001300 9451200

More information

履  歴  書

履  歴  書 ,,,,,, Carboplatin and Monthly Paclitaxel Carboplatin and Weekly Paclitaxel 8(1), 25-34 (2006) Masayoshi KOINUMA, Takahisa YAMANASHI, Miwako KAMEI, Makoto SHIRAGAMI, The realities and Medical Expense of

More information

0 0 0 0............ PNEC.............................. PNECsed.................. 0 0 0 0 PNEC logpow. * Oncorhynchus mykisslc0. mg/l UFs0,000 0.000 mg/l0. µg/lpnec PNECwater PNECwater * Sangster, J. ()

More information

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN J Life Sci Res 2014; 12: 15-19 2014 Osaka Prefecture University Journal of Life Science Research Online ISSN 2186-5809 583-8555 3-7-30 577-8567 3-1-1 2014 9 11 2014 10 21 Exposure mild-level LED light

More information

An Approach to the Manchuria 731 Unit Keiichi TSUNEISHI Kanagawa University Research Society for 15 years War and Japanese Medical Science and Service ournal of Research Society for 15 years War and Japanese

More information

橡96-07.PDF

橡96-07.PDF 1 967 2482 CAS 50000 CH 2 O 30.03 2952% 12.5 % 1. 2) -92 2) -19.5 2) 5085 3) 424 3) 7.073.0% 4) 20 d 4 0.815 5) 1.03 ( = 1) 5) 1.33 kpa (10 mmhg) (-88.0) 2) log Pow0.35 ( ) 6) 0.35 ( ) 7) 1) m/z 29 ( 1.0

More information

<93C195CA D834F E696E6464>

<93C195CA D834F E696E6464> 45 I I Diabetes and Heart: Insight by Imaging Juhani Knuuti Turku PET Centre, Turku University Central Hospital II I Development and Application of Beta-Amyloid Imaging Agents Chet A. Mathis Department

More information

第 8 回ライフサイエンス シンポジウム 石川ひろの 13:45-14:30 講演 (2) 健康を決める力 としてのヘルスリテラシー 東京大学大学院医学系研究科准教授 石川ひろの

第 8 回ライフサイエンス シンポジウム 石川ひろの 13:45-14:30 講演 (2) 健康を決める力 としてのヘルスリテラシー 東京大学大学院医学系研究科准教授 石川ひろの 第 8 回ライフサイエンス シンポジウム 石川ひろの 13:45-14:30 講演 (2) 健康を決める力 としてのヘルスリテラシー 東京大学大学院医学系研究科准教授 石川ひろの 2014.02.20-25 - 第 8 回ライフサイエンス シンポジウム 石川ひろの 石川ひろの ( いしかわひろの ) 東京大学医学部健康科学 看護学専攻卒業 同大学院医学系研究科健康社会学分野および Johns Hopkins

More information

& Vol.2 No (Mar. 2012) 1,a) , Bluetooth A Health Management Service by Cell Phones and Its Us

& Vol.2 No (Mar. 2012) 1,a) , Bluetooth A Health Management Service by Cell Phones and Its Us 1,a) 1 1 1 1 2 2 2011 8 10, 2011 12 2 1 Bluetooth 36 2 3 10 70 34 A Health Management Service by Cell Phones and Its Usability Evaluation Naofumi Yoshida 1,a) Daigo Matsubara 1 Naoki Ishibashi 1 Nobuo

More information

Table 1 Survival rates of infected mice given antibiotic doses producing peak serum a) S. aurcus Smith Challenge dose :7 ~10 (5% mucin) CFU/mouse. LD50: 1 ~103 (5% mucin) CFU/mouse. Table 2 Survival rates

More information

Letter566.pdf

Letter566.pdf http://nibs.lin.gr.jp/ 2 2 29 1000 1990 27.4 30.0 2009 13.5 49.6 1995 475 87 2009 292 332 1995 54 22 2009 70 101 57 1 2011 3 3 13 2008 3 2009 5 11 6 4.5 2 cm 3 1 1 2 3 S 100 4 Vimentin Melan A 5 3 HE Canine

More information

小児感染免疫第25巻第2号

小児感染免疫第25巻第2号 2013 Vol. 25No. 2175 44 1972 28 1 Kikuchi s diseasekikuchifujmoto diseasehistiocytic necrotizing lymphadenitis Histiocytic necrotizing lymphadenitis, Kikuchi s disease, KikuchiFujimoto disease, subacute

More information

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin

More information

第57巻2号/投稿規定・目次・表2・奥付・背

第57巻2号/投稿規定・目次・表2・奥付・背 Feature articlesdiet in a society with a growing elderly population and a low birth rate Original The problems of breastfeeding Kazuhisa Maeda, Ryuji Mitani, Satoko Endo, Yoshika Saijo, and Toshihiro

More information

平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書

平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書 226 227 µ 228 Ω 229 230 0 ppb 2000ppb DG subthreshold (µa) 91 ± 59 86 ± 68 max stim. (µa) 755 ± 287 n=37 678 ± 300 max PS (mv) 8.7 ± 3.9 7.7 ± 4.3 n=61 CA1 subthreshold (µa) 36 ± 26 32 ± 13 max stim. (µa)

More information

C/NC : committed/noncommitted

C/NC : committed/noncommitted C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

More information

健康栄養学部報-表紙2号

健康栄養学部報-表紙2号 1 5 7 7 8 11 13 14 16 16 18 19 19 20 21 21 21 22 23 23 27 28 29 31 33 33 34 35 37 3 37 37 38 38 38 39 40 40 41 43 44 46 48 50 51 53 55 57 59 61 62 65 66 68 69 70 71 4 7 8 9 13 H 14 H 15 , A C &,,, -A-.

More information

Caloric Behavior of Chemical Oscillation Reactions Shuko Fujieda (Received December 16, 1996) Chemical oscillation behavior of Belousov- Zhabotinskii

Caloric Behavior of Chemical Oscillation Reactions Shuko Fujieda (Received December 16, 1996) Chemical oscillation behavior of Belousov- Zhabotinskii Caloric Behavior of Chemical Oscillation Reactions Shuko Fujieda (Received December 16, 1996) Chemical oscillation behavior of Belousov- Zhabotinskii (BZ) and Briggs- Rauscher (BR) reactions was followed

More information

) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R

) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R Vol. 12 No. 2 2002 389 397 Λ1 Λ2 16 10 30 1 2 Lawton Philadelphia Geriatric Center Affect Rating ScaleARS Lawton ARS + ARS 6 2 ARS 2 12:00 15:0017:00 11:30 16:00 1 2 ARS 1 2 ARS QOL QOL QOL 1) QOL QOL

More information

研究論集Vol.16-No.2.indb

研究論集Vol.16-No.2.indb Vol. No. pp. - SSTSST SST Eriko HARADA This study was aimed at students with hearing impairments to improve their social skills and self-esteem by putting social skills training SSTinto practice and discussing

More information

VOL. 34 S-2 CHEMOTH8RAPY 913

VOL. 34 S-2 CHEMOTH8RAPY 913 VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(

More information

表紙PDF作成用/PDF表紙作成用

表紙PDF作成用/PDF表紙作成用 2008 Vol.50 No.2 Jpn J School Health Jpn J School Health Graduate School of International Studies, J.F. Oberlin University Research Fellow of the Japan Society for the Promotion of Science College of

More information

24回日本エイズ学会誌1_ indd

24回日本エイズ学会誌1_ indd 10 ICAAP 11 24 9:40 10:10 1 B1F 1. 10 Myung-Hwan Cho 2. Zahid Hussein President of AIDS Society of Asia and the Pacific ASAP 11 24 13:10 15:40 1 B1F 1 13:10 13:55 PS1-1 ART in the Developing World: Progress

More information

untitled

untitled Communication Center for Food and Health Sciences EU RegulationEUNo 1129/2011, 11 Nov 2011 26 24 5 18 1 135-0004 3-14-3 2 TEL 03-5669-8601 FAX 03-6666-9132 http://www.ccfhs.or.jp/ E-Mail 8.shokkakyo@ccfhs.or.jp

More information

NINJAL Research Papers No.8

NINJAL Research Papers No.8 (NINJAL Research Papers) 8: 177 196 (2014) ISSN: 2186-134X print/2186-1358 online 177 3 3 3 1940 3 late adoption real time 3 apparent time * 1. 1 2 3 1.1 3 1 1953 * 2014 3 18 2014 5 13 109 NINJAL 2012

More information

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference

More information

表紙PDF作成用/PDF表紙作成用

表紙PDF作成用/PDF表紙作成用 2010 Vol.52 No.2! ! Jpn J School Health Jpn J School Health Jpn J School Health! Jpn J School Health Aichi University of Education Nagoya University "! Jpn J School Health! Graduate School of Public Health

More information

Fig. 1 Chemical structure of DL-8280

Fig. 1 Chemical structure of DL-8280 Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.

More information

Microsoft Excelを用いた分子軌道の描画の実習

Microsoft Excelを用いた分子軌道の描画の実習 J. Comput. Chem. Jpn.,Vol.9, No.4, pp.177 182 (2010) 2010 Society of Computer Chemistry, Japan Microsoft Excel a*, b, c a, 790-8577 2-5 b, 350-0295 1-1 c, 305-8568 1-1-1 *e-mail: nagaoka@ehimegw.dpc.ehime-u.ac.jp

More information

Microsoft Word - TIP2006-3-TGN doc

Microsoft Word - TIP2006-3-TGN doc TIP 2006 3 Vol 21 No3 p21-24 TGN1412 I NPO 3 13 15 [1,2] I TGN1412 18 40 1 ICU 19 6 4 3 [3] The Medicines and Healthcare Products Regulatory Agency MHRA [2] TGN1412 TGN1412 CD28-SuperMAB T TGN1412 T superagonistic

More information

CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover

CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover VOL.26 S-2 CHEMOTHERAPY Gentamicin (GM), Dibekacin (DKB), Tobramycin Fig. 1 Protein concentration and protein binding rate Table 2 Protein binding rate of PC-904 in serum of healthy adults, and patients

More information

Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-

Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3- Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-14-ethyl-12,

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

Microsoft Word - プログラム詳細.doc

Microsoft Word - プログラム詳細.doc SL1 Nanobiology at UCLA and the CNSI Using Nanoparticle Design to Study Biocompatability and Material Toxicity André Nel, MD, PhD Division of NanoMedicine, Department of Medicine and the California NanoSystems

More information

Liikenneturva Liikenneturva

Liikenneturva Liikenneturva Research and Training Humaani Ltd. 1 1 1 2 2 2.1 2.2 2014 2.3 2.4 2.5 Liikenneturva Liikenneturva 56 2.6 3 2.7 2.8 530 580 2013254 10 4.8 3 3 3.1 50 4 3.2 3.2.1 3.2.2 4.36 5 3.69 5 1 97.9 3.2.3 http://www.youtube.com/user/liikenneturva/videos

More information

平成14年8月22日

平成14年8月22日 7 14 11 26 7 18 7 7 ( ) 2 7 5 3 1. 1) 2) 3) 4) 5) 6) 2. 3. 4 4. 5. 6. 5 6 7 1. 8 2. 8 3. 12 4. 15 5. 19 6. 23 7. 26 8. 28 7 1. 2000 12 2 2000 12 6 7 2001 13 2 5 6 6 1) 2) 3) 4) 5) 6) 2. 2001 13 3 1) 8

More information

LMS LMS 2014 LMS 2 Moodle 2. LMS LMS e-learning Web LMS MOOC Moodle LMS ( 1 ) ( 2 ) ( 3 ) 24 ( 4 ) ( 5 ) ( 6 ) 1 LMS Web CS LMS Instructu

LMS LMS 2014 LMS 2 Moodle 2. LMS LMS e-learning Web LMS MOOC Moodle LMS ( 1 ) ( 2 ) ( 3 ) 24 ( 4 ) ( 5 ) ( 6 ) 1 LMS Web CS LMS Instructu LMS 1 2 2 LMS Blended-Learning CS PC Web LMS MOOC CS PC LMS LMS Requested Features for Mobile Learning Application dedicated to LMS Toshiyuki Kamada 1 Yasushi Kodama 2 Yuki Terawaki 2 Abstract: The blended-learning

More information

PM µm PM CLRTAP 13 EANET SPM 10 µm µm PM2.5 PM2.5 SPM 1997 PM2.5 PM2.5 PM2.5 PM2.5 PM2.5 SPM PM2.5 PM2.5 PM2.5 PM2.5 PM2.

PM µm PM CLRTAP 13 EANET SPM 10 µm µm PM2.5 PM2.5 SPM 1997 PM2.5 PM2.5 PM2.5 PM2.5 PM2.5 SPM PM2.5 PM2.5 PM2.5 PM2.5 PM2. PM2.5 2.5 µm PM2.5 1950 1979 CLRTAP 13 EANET2001 1972 SPM 10 µm µm PM2.5 PM2.5 SPM 1997 PM2.5 PM2.5 PM2.5 PM2.5 PM2.5 SPM PM2.5 PM2.5 PM2.5 PM2.5 PM2.5 PM2.5 PM2.5 15 2 Particulate Matter; PM 2.5 µm PM2.5

More information

1 Department of Legal Medicine, Toyama University School of Medicine 2 3 4 5 6 7 8 Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama VEGF Key words

More information

プラズマ・核融合学会

プラズマ・核融合学会 1. Philosophy of Radiological Protection and Radiation Hazard Protection Law 1) Oita University of Nursing and Health Sciences, Oita, OITA 870-1201, Japan 2) National Institute for Fusion Science, Toki,

More information

final.indd

final.indd The Water Voice of the Tonle Sap Lake: Fishing, Drinking, Bathing and Eating on the Water: A Story of People's Dependency on Water in the Tonle Sap Lake, Cambodia Asian Development Bank

More information

1) Garner J. S.: The Hospital Infection Control Practices Advisory Committee, CDC, Guidelines for Isolation Precautions in Hospitals, 1996. http://wonder.cdc.gov/wonder/prevguid/ p0000419/p0000419.asp.

More information